Ocular Therapeutix, Inc. (OCUL)

Name: Ocular Therapeutix, Inc. (OCUL) — institutional 13F ownership
Creator: Fundocap
License: https://creativecommons.org/licenses/by/4.0/

9.99 USD-1.48%

Ocular Therapeutix, Inc. (OCUL) is not among the 30 most-held stocks of the tracked superinvestor set. Price 9.99 USD.

Prev Close10.14

Open10.15

Day Range9.9 – 10.26

52 Week Range6.23 – 16.44

Volume4,100,600

Avg Volume (3M)2,541,660

Market Cap—

BetaVolatility vs the market. Above 1: swings harder than the index.—

P/E (TTM)Price/Earnings: share price over annual profit — what you pay per $1 of earnings. Compare within the sector.—

EPS (TTM)Annual net profit per share.—

Avg Price Target—

Dividend YieldAnnual dividend over share price.—

Some company data is temporarily unavailable from the data provider; basic price data is shown from a fallback source. Refresh in a few minutes.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Frequently Asked Questions

Which superinvestors own OCUL?

Ocular Therapeutix, Inc. (OCUL) is not among the 30 most-held stocks of the tracked superinvestor set.

Is institutional sentiment on OCUL bullish or bearish?

OCUL is not among the 30 most-held stocks of the superinvestor set, so net buyer/seller counts are not computed for it.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.